Cargando…
Carcinogen‐induced tumors in SFN‐transgenic mice harbor a characteristic mutation spectrum of human lung adenocarcinoma
The landscape of genetic alterations in disease models such as transgenic mice or mice with carcinogen‐induced tumors has provided a huge amount of information that has shed light on the process of tumorigenesis in human non‐small‐cell lung cancer (NSCLC). We have previously identified stratifin (SF...
Autores principales: | Kim, Yunjung, Shiba‐Ishii, Aya, Ramirez, Karina, Muratani, Masafumi, Sakamoto, Noriaki, Iijima, Tatsuo, Noguchi, Masayuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676126/ https://www.ncbi.nlm.nih.gov/pubmed/31144406 http://dx.doi.org/10.1111/cas.14081 |
Ejemplares similares
-
DNA hypomethylation-related overexpression of SFN, GORASP2 and ZYG11A is a novel prognostic biomarker for early stage lung adenocarcinoma
por: Husni, Ryan Edbert, et al.
Publicado: (2019) -
Ovarian carcinoma immunoreactive antigen domain 2 controls mitochondrial apoptosis in lung adenocarcinoma
por: Hong, Jeongmin, et al.
Publicado: (2021) -
miR‐3941: A novel microRNA that controls IGBP1 expression and is associated with malignant progression of lung adenocarcinoma
por: Sato, Taiki, et al.
Publicado: (2017) -
Stratifin accelerates progression of lung adenocarcinoma at an early stage
por: Shiba-Ishii, Aya, et al.
Publicado: (2015) -
High expression of Ras‐specific guanine nucleotide‐releasing factor 2 (RasGRF2) in lung adenocarcinoma is associated with tumor invasion and poor prognosis
por: Nakagawa, Tomoki, et al.
Publicado: (2021)